Taken together, these findings illustrate the significance of CD36 as a critical mediator of hepatic fatty acid uptake, particularly in contexts characterized by elevated fatty acid levels such as OA, and the upregulation of CD36 following Ex-4 treatment offers protection against steatosis via the modulation of MALAT1 expression. This evidence concerns the gene MALAT1 and steatosis.